FINWIRES · TerminalLIVE
FINWIRES

由於美國和伊朗未能達成和平協議,美元走強,黃金價格再次下跌。

-- 黃金價格週一早盤可望連續第二天下跌,美元走強。此前,美國和伊朗週末的談判未能達成和平協議,導致霍爾木茲海峽仍被封鎖,並持續造成史上最嚴重的石油供應衝擊。 5月交割的黃金期貨價格下跌51.90美元,至每盎司4,736.00美元。 美伊談判破裂,未能達成結束戰爭的協議。這場戰爭導致霍爾木茲海峽被封鎖,波斯灣國家供應的石油佔全球每日石油需求的20%。談判破裂後,美國計劃封鎖伊朗港口,並阻止任何向伊朗繳納通行費的船隻通過海峽,繼續切斷石油供應。 自2月28日戰爭爆發以來,油價已上漲近一半,推高了美國和其他地區的通膨,也終結了對美國降息的預期。美國上周公布的3月消費者物價指數(CPI)年化漲幅達3.3%,高於前一個月的2.4%。 美元早盤走強,ICE美元指數最新上漲0.25點至98.90。美國公債殖利率基本持平,兩年期公債殖利率最新報3.81%,與前一日持平;十年期公債殖利率為4.33%,下跌1.0個百分點。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF